Cingulate Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.26

+0.02 (+0.47%)

As of Nov 7, 2:36 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +237.6% upside

Low Target $9.95

Average Target $14.38

High Target $17.66

Current Price $4.26

Current
$4.26

Target
$14.38

$9.95 $14.38 avg $17.66

Scenario Analysis

Bear Case

$9.95

133.6%

Low target

Base Case

$14.38

+237.6%

Avg target

Bull Case

$17.66

+314.6%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$11.89

-64.2% from high

52-Week Low

$3.16

+34.8% from low

Target vs 52W High

$14.38

+20.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-1.7%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+8.4%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.5%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+15.3%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+180.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.1%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+164.3%